Private Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Private Wealth Partners's NVO Position: Q3 2026 in Review
Private Wealth Partners increased its Novo Nordisk (NVO) stake by 7.3% in Q3 2026, buying an estimated $104K and bringing the position to 32,985 shares worth $1.25M. The position accounts for 0.09% of the portfolio, ranked #92.
Private Wealth Partners first reported a position in NVO in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.57M in Q1 2025. 1,226 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Private Wealth Partners held 32,985 shares of Novo Nordisk worth $1.25M as of Q3 2026.
- Private Wealth Partners bought 2,250 Novo Nordisk shares in Q3 2026, an estimated $104K.
- Novo Nordisk made up 0.09% of Private Wealth Partners's portfolio in Q3 2026, its #92 holding.
- Private Wealth Partners first reported a position in Novo Nordisk in Q2 2013 and has held it in 27 quarters since.
- Private Wealth Partners's Novo Nordisk position peaked at $4.57M in Q1 2025.
- 1,226 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Private Wealth Partners's 13F filing for Q3 2026, filed 22 Oct 2026.